NCT03200379View on ClinicalTrials.gov

Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan

RecruitingOBSERVATIONAL
Enrollment

150,000

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

June 15, 2037

Study Completion Date

June 15, 2037

Conditions
Hepatitis C, Chronic
Interventions
OTHER

directly acting antivirals (DAAs)

Eligible subjects would be those CHC patients who receive approved DAA in the daily practice in Taiwan. No clinical developing medications will be allocated patients.

Trial Locations (1)

807

RECRUITING

HepatobiliaryDivision, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER